I couldn't live without ... PointClickCare Secure Conversations
Profile: Mastering by example
Day in the Life: Sniffing out wandering residents
by Shelly Mesure
By Gary Tetz
By Eleanor Feldman Barbera
Drugmakers Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LCC will pay up to $109 million in a settlement over an alleged scheme to provide doctors with free units of its knee-injection drug Hyalgan in return for purchase of the treatment.